Varicella at "Casa Garrahan", 2008-2013: Assessment of postexposure prophylaxis measures

Arch Argent Pediatr. 2015 Jun;113(3):237-43. doi: 10.5546/aap.2015.eng.237.
[Article in English, Spanish]

Abstract

Introduction: Casa Garrahan (CG) accommodates children with complex conditions referred nationwide; these children are seen in children's hospitals located in the Autonomous City of Buenos Aires. Varicella is a highly-contagious disease, with attack rates of up to 90% among susceptible individuals. In closed communities, the implementation of outbreak control measures is critical.

Objectives: To describe the characteristics of children exposed to varicella at CG, the implemented prophylaxis measures and their effectiveness.

Methods: Prospective, cohort study. Children exposed to varicella at CG between2008 and 2013, their demographic and clinical characteristics, immunization and/or history of varicella, prophylaxis measures, and secondary attack rate were assessed.

Results: N: 107. Fifty-three percent (n: 57) were girls. Their median age was 84 months old [interquartile range (IQR): 24-144]. Ninety-five percent (n: 102) had an underlying disease [hemato-oncological disease: 39% (n: 42); neurological disease: 18% (n: 19); congenital heart disease: 9% (n: 10); and post-operative period: 65 (n: 6)]. Fifty percent had some degree of immunosuppression (n: 54). Twenty-nine percent (n: 31) referred to have had varicella; 27% (n: 29) indicated that they never had the infection; and 41% (n: 44) did not recall a history of varicella. Only 3% (n: 3) had been vaccinated. Based on their immune status, age and history of varicella, acyclovir was indicated as prophylaxis in 61% (n: 65); immunization in 10% (n: 10); and gamma globulin in 1 patient. No adverse effects were observed in relation to the different prophylaxis measures. No secondary cases were observed at 30 days.

Conclusions: Implemented measures were effective to prevent secondary cases. Among healthy and immunocompromised children, prophylaxis with acyclovir was effective and well-tolerated.

Publication types

  • Observational Study

MeSH terms

  • Acyclovir / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Argentina
  • Chickenpox / prevention & control*
  • Chickenpox Vaccine*
  • Child
  • Child, Preschool
  • Cohort Studies
  • Female
  • Hospitals, Pediatric
  • Humans
  • Male
  • Post-Exposure Prophylaxis*
  • Prospective Studies

Substances

  • Antiviral Agents
  • Chickenpox Vaccine
  • Acyclovir